Comparison of warfarin versus DOACs in patients with concomitant indication for oral anticoagulation undergoing TAVI; results from the ATLAS registry
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-019-01968-w
Abstract: The optimal antithrombotic therapy for patients undergoing TAVI with concomitant indication for oral anticoagulation remains unclear. In this high-risk population group, there is a paucity of data with regards to the use of DOACs. In… read more here.
Keywords: anticoagulation; undergoing tavi; concomitant indication; indication oral ... See more keywords
Bioresorbable scaffold implantation in patients with indication for oral anticoagulation: A propensity matched analysis.
Sign Up to like & getrecommendations! Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2016.11.280
Abstract: OBJECTIVES To examine ischemic and bleeding outcomes in patients on triple antithrombotic therapy (TAT) compared with dual antiplatelet therapy (DAPT) after the implantation of bioresorbable scaffolds (BRS). BACKGROUND The optimal antithrombotic regimen in patients undergoing… read more here.
Keywords: bioresorbable scaffold; scaffold implantation; implantation; indication oral ... See more keywords